title: Mechanism of tachycardia caused by intracarotid PGE2 in conscious ewes.
abstract: Conscious adult ewes prepared with nonocclusive indwelling vascular catheters were used to determine the mechanism by which heart rate increases during central administration of prostaglandin E2 (PGE2). Heart rate increased 14 bpm during steady-state intracarotid infusion of PGE2, 10 ng/kg/min (P less than 0.05). Intravenous atropine methyl bromide, 1 mg/kg, increased heart rate 26 bpm (P less than 0.05) 5 min after injection. Heart rate remained elevated 30 min after injection. The heart rate response to PGE2 plus atropine was greater than the heart rate response to either atropine or PGE2 alone (P less than 0.05). Propranolol, 1 mg/kg bolus plus intravenous infusion, 0.025 mg/kg/min, did not change resting heart rate. Propranolol attenuated but did not abolish the increase in heart rate caused by intracarotid PGE2. Although heart rate increased in response to PGE2 after administration of either propranolol or atropine alone, the combination of propranolol and atropine prevented any further increase in heart rate during subsequent PGE2 infusion. The increase in heart rate when all three drugs were given together was not different from the increase observed during atropine alone. Thus, both beta-adrenergic activation and muscarinic deactivation contribute to the PGE2-induced tachycardia.
authors.forename: B A
authors.initials: BA
authors.lastname: Breuhaus
authors.forename: J E
authors.initials: JE
authors.lastname: Chimoskey
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001286:Atropine Derivatives / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002316:Cardiotonic Agents / Q000494:pharmacology; D002339:Carotid Arteries; D003243:Consciousness; D015232:Dinoprostone; D004347:Drug Interactions; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D007269:Injections, Intra-Arterial; D011433:Propranolol / Q000494:pharmacology; D011458:Prostaglandins E / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000187:drug effects; D012756:Sheep; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*
chemical_list: D000319:Adrenergic beta-Antagonists; D001286:Atropine Derivatives; D002316:Cardiotonic Agents; D011458:Prostaglandins E; D011943:Receptors, Adrenergic, beta; D011976:Receptors, Muscarinic; C006649:methylatropine; D011433:Propranolol; D015232:Dinoprostone; D000109:Acetylcholine